Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	IPO	Equity Grants	ESPP	Class A, Class B, and Class F Common Stock	Class A, Class B, and Class F Common Stock IPO	Class A, Class B, and Class F Common Stock Equity Grants	Class A, Class B, and Class F Common Stock ESPP	Additional Paid-In Capital	Additional Paid-In Capital IPO	Additional Paid-In Capital Equity Grants	Additional Paid-In Capital ESPP	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Redeemable Noncontrolling Interest	Convertible Preferred Stock Preferred Stock	Convertible Preferred Stock Preferred Stock IPO
Balance at beginning of period at Dec. 31, 2018															$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	$ 0
Balance at end of period at Dec. 31, 2019															0
Balance at beginning of period (in shares) at Dec. 31, 2018					178,446,087											109,090,908
Balance at beginning of period at Dec. 31, 2018	(378,355)				$ 5				$ 230,922				$ (2,618)	$ (1,006,253)		$ 399,589
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercises and vesting of early exercised Class A common stock options (in shares)							6,771,873
Exercises and vesting of early exercised Class A common stock options			$ 2,940				$ 1				$ 2,939
Repurchase of unvested Class A common stock related to early exercised stock (in shares)					(8,595)
Repurchase of unvested Class A common stock related to early exercised stock options	(11)								(11)
Repurchase of Class A common stock (in shares)					(2,775,000)
Repurchase of Class A common stock	(9,074)								(9,074)
Repurchase of unvested restricted stock awards (in shares)					(360,552)
Exercise of warrant (in shares)					34,816,317
Exercise of warrant	1				$ 1
Issuance of Class A common stock in connection with acquisitions (in shares)					3,267,792
Issuance of Class A common stock in connection with acquisitions	192								192
Stock-based compensation	10,222								10,222
Other comprehensive income (loss), net	(1,522)												(1,522)
Net income (loss)	119,040													119,040
Balance at end of period (in shares) at Dec. 31, 2019					220,157,922											109,090,908
Balance at end of period at Dec. 31, 2019	(256,567)				$ 7				235,190				(4,140)	(887,213)		$ 399,589
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Class A common stock in exchange for noncontrolling equity interest	1,500								1,500						(1,500)
Acquisition of noncontrolling interest															2,556
Net income (loss)	747														(747)
Balance at end of period at Dec. 31, 2020	309														309
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercises and vesting of early exercised Class A common stock options (in shares)					3,559,168
Exercises and vesting of early exercised Class A common stock options	2,303								2,303
Repurchase of unvested Class A common stock related to early exercised stock (in shares)					(425,001)
Repurchase of Class A common stock (in shares)					(249,000)
Repurchase of Class A common stock	(1,766)								(1,766)
Issuance of common stock warrants and options in connection with an acquisition	39,040								39,040
Issuance of Class A common stock in connection with acquisitions (in shares)					2,479,996
Issuance of Class A common stock in connection with acquisitions	106,133								106,133
Issuance of common stock warrants in connection with lease modification	433								433
Issuance of Class A common stock (in shares)					764,472
Issuance of Class A common stock	9,318								9,318
Issuance of Class A common stock in exchange for noncontrolling equity interest (in shares)					76,844
Issuance of Class A common stock in exchange for noncontrolling equity interest	1,500								1,500						(1,500)
Stock-based compensation	61,504								61,504
Other comprehensive income (loss), net	4,744												4,744
Net income (loss)	(125,187)													(125,187)
Balance at end of period (in shares) at Dec. 31, 2020					226,364,401											109,090,908
Balance at end of period at Dec. 31, 2020	(158,545)				$ 7				453,655				604	(1,012,400)		$ 399,589
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	108														(108)
Balance at end of period at Dec. 31, 2021	201														$ 201
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercises and vesting of early exercised Class A common stock options (in shares)							4,326,297
Exercises and vesting of early exercised Class A common stock options			$ 29,761								$ 29,761
Repurchase of Class A common stock (in shares)					(604,509)
Exercise of warrant (in shares)					6,229,081
Issuance of Class A common stock (in shares)					90,830			42,303
Issuance of Class A common stock	2,503			$ 2,877					2,503			$ 2,877
Issuance of Class A common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)					22,500,000
Issuance of Class A common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions	1,747,971				$ 1				1,747,970
Conversion of securities to common stock (in shares)					7,050,049	109,090,908											(109,090,908)
Conversion of securities to common stock	392,170	$ 0				$ 3			392,170	$ 399,586							$ (399,589)
Stock-based compensation	131,965								131,965
Other comprehensive income (loss), net	(46,058)												(46,058)
Net income (loss)	35,446													35,446
Balance at end of period (in shares) at Dec. 31, 2021					375,089,360											0
Balance at end of period at Dec. 31, 2021	$ 2,138,090				$ 11				$ 3,160,487				$ (45,454)	$ (976,954)		$ 0